ロード中...
Efficacies of Cabotegravir and Bictegravir against drug-resistant HIV-1 integrase mutants
BACKGROUND: Integrase strand transfer inhibitors (INSTIs) are the class of antiretroviral (ARV) drugs most recently approved by the FDA for the treatment of HIV-1 infections. INSTIs block the strand transfer reaction catalyzed by HIV-1 integrase (IN) and have been shown to potently inhibit infection...
保存先:
| 出版年: | Retrovirology |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5956922/ https://ncbi.nlm.nih.gov/pubmed/29769116 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12977-018-0420-7 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|